Flutamide inhibits nifedipine- and interleukin-1β-induced collagen overproduction in gingival fibroblasts

Journal of Periodontal Research

Volumn 45, Issue 4, 2010, Pages 451-457

  Lu, H K ^a,b   Tseng, C C ^c   Lee, Y H ^d   Li, C L ^a   Wang, L F ^e  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d Departments of Physiology   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Androgen receptor; Collagen; Dihydropyridine induced gingival overgrowth; Interleukin 1

Indexed keywords

1,4 DIHYDROPYRIDINE; 1,4-DIHYDROPYRIDINE; ANDROGEN RECEPTOR; ANTIANDROGEN; CALCIUM CHANNEL BLOCKING AGENT; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE I, ALPHA 1 CHAIN; CONNECTIVE TISSUE GROWTH FACTOR; DIHYDROPYRIDINE DERIVATIVE; FLUTAMIDE; INTERLEUKIN 1BETA; NIFEDIPINE;

ARTICLE; CASE CONTROL STUDY; CELL CULTURE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FEMALE; FIBROBLAST; GINGIVA; GINGIVA OVERGROWTH; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; TIME;

ANDROGEN ANTAGONISTS; CALCIUM CHANNEL BLOCKERS; CASE-CONTROL STUDIES; CELL CULTURE TECHNIQUES; CELLS, CULTURED; COLLAGEN; COLLAGEN TYPE I; CONNECTIVE TISSUE GROWTH FACTOR; CULTURE MEDIA, CONDITIONED; DIHYDROPYRIDINES; DRUG SYNERGISM; FEMALE; FIBROBLASTS; FLUTAMIDE; GINGIVA; GINGIVAL OVERGROWTH; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; NIFEDIPINE; RECEPTORS, ANDROGEN; TIME FACTORS;

EID: 77954858401     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2009.01255.x     Document Type: Article

References (42)

1. Abernethy DR, Schwartz JB. Pharmacokinetics of calcium antagonists under development. Clin Pharmacokinet 1988, 15:1-14.
2. Scholz H. Pharmacological aspects of calcium channel blockers. Cardiovasc Drugs Ther 1997, 10(suppl 3):869-872.
3. Bailey DG, Dresser GK. Interactions between grapefruit juice and cardiovascular drugs. Am J Cardiovasc Drugs 2004, 4:281-297.
4. Huang WT, Lu HK, Chou HH, Kuo MYP. Immunohistochemical analysis of Th1/Th2 cytokine profiles and androgen receptor expression in the pathogenesis of nifedipine-induced gingival overgrowth. J Periodontal Res 2003, 38:422-427.
5. Lu HK, Chou HP, Li CL, Wang MY, Wang LF. Stimulation of cells derived from nifedipine-induced gingival overgrowth with Porphyromonas gingivalis, lipopolysaccharide, and interleukin-1beta. J Dent Res 2007, 86:1100-1104.
6. Chae HJ, Ha MS, Yun DH. Mechanism of cyclosporine-induced overgrowth in gingiva. J Dent Res 2006, 85:515-519.
7. Black SA, Palamakumbura AH, Stan M, Trackman PC. Tissue-specific mechanisms for CCN2/CTGF persistence in fibrotic gingiva: interactions between cAMP and MAPK signaling pathways, and prostaglandin E2-EP3 receptor mediated activation of the c-JUN N-terminal kinase. J Biol Chem 2007, 282:15416-15429.
8. Sobral LM, Montan PF, Martelli-Junior H, Graner E, Coletta RD. Opposite effects of TGF-beta1 and IFN-gamma on transdifferentiation of myofibroblast in human gingival cell cultures. J Clin Periodontol 2007, 34:397-406.
9. Guo J, Wang W, Yao L, Yan F. Local inflammation exacerbates cyclosporine A-induced gingival overgrowth in rats. Inflammation 2008, 31:399-407.
10. Soory M, Kasasa SC. The effects of epidermal growth factor, interleukin-1, and phenytoin, alone and in combination, on C19 steroid conversions in fibroblasts. J Periodontol 1997, 68:819-826.
11. Black SA, Trackman PC. Transforming growth factor-beta1 (TGFbeta1) stimulates connective tissue growth factor (CCN2/CTGF) expression in human gingival fibroblasts through a RhoA-independent, Rac1/Cdc42-dependent mechanism: statins with forskolin block TGFbeta1-induced CCN2/CTGF expression. J Biol Chem 2008, 283:10835-10847.
12. Gressner OA, Gressner AM. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int 2008, 28:1065-1079.
13. Leask A. Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. Cell Signal 2008, 20:1409-1414.
14. Shi-Wen X, Leask A, Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev 2008, 19:133-144.
15. Nishida M, Sato Y, Uemura A. P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis. EMBO J 2008, 27:3104-3115.
16. de Winter P, Leoni P, Abraham D. Connective tissue growth factor: structure-function relationships of a mosaic, multifunctional protein. Growth Factors 2008, 26:80-91.
17. Trackman PC, Kantarci A. Connective tissue metabolism and gingival overgrowth. Crit Rev Oral Biol Med 2004, 15:165-175.
18. Kantarci A, Black SA, Xydas CE. Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis. J Pathol 2006, 210:59-66.
19. Ingles E, Rossmann JA, Caffesse RG. New clinical index for drug-induced gingival overgrowth. Quintessence Int 1999, 30:467-473.
20. Kim JY, Park SH, Cho KS. Mechanism of azithromycin treatment on gingival overgrowth. J Dent Res 2008, 87:1075-1079.
21. Markova MS, Zeskand J, McEntee B, Rothstein J, Jimenez SA, Siracusa LD. A role for the androgen receptor in collagen content of the skin. J Invest Dermatol 2004, 123:1052-1056.
22. Mangelsdorf DJ, Thummel C, Beato M. The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
23. McKenna NJ, O'Malley BW. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002, 108:465-474.
24. Ikeda Y, Aihara K, Sato T. Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis. J Biol Chem 2005, 280:29661-29666.
25. Gemmell E, Marshall RI, Seymour GJ. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000 1997, 14:112-143.
26. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998, 9:248-266.
27. Kida Y, Kobayashi M, Suzuki T. Interleukin-1 stimulates cytokines, prostaglandin E2 and matrix metalloproteinase-1 production via activation of MAPK/AP-1 and NF-kappaB in human gingival fibroblasts. Cytokine 2005, 29:159-168.
28. Ikeda M, Ikeda U, Kano S. Interleukin-1 suppresses mesangial cell growth via inhibition of Ca2+ entry. Cytokine 1991, 3:131-133.
29. Gong Y, Blok LJ, Perry JE, Lindzey JK. Calcium regulation of androgen receptor expression in the human prostate cancer line LNCaP. Endocrinology 1995, 136:2172-2178.
30. Chen CF, Corbley MJ, Robertys TM, Hess P. Voltage-sensitive calcium channels in normal and transformed 3T3 fibroblasts. Science 1988, 239:1024-1026.
31. Baumgarten LB, Toscas K, Villereal ML. Dihydropyridine-sensitive L-type Ca2+ channels in human foreskin fibroblast cells. Characterization of activation with the growth factor Lys-bradykinin. J Biol Chem 1992, 267:10524-10530.
32. Veer Reddy GP, Barrack ER, Dou QP. Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer. J Cell Biochem 2006, 98:1408-1423.
33. Harel-Raviv M, Eckler M, Lalani K, Raviv E, Gornitsky M. Nifedipine-induced gingival hyperplasia. A comprehensive review and analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995, 79:715-722.
34. Kataoka M, Kido J, Shinohara Y, Nagata T. Drug-induced gingival overgrowth-a review. Biol Pharm Bull 2005, 28:1817-1821.
35. Uzel MI, Kantarci A, Hong HH. Connective tissue growth factor in drug-induced gingival overgrowth. J Periodontol 2001, 72:921-931.
36. Wakabayashi K, Miyachi H, Hashimoto Y, Tanatani A. Novel non-steroidal/non-anilide type androgen antagonists: discovery of 4-substituted pyrrole-2-carboxamides as a new scaffold for androgen receptor ligands. Bioorg Med Chem 2005, 13:2837-2846.
37. Klotz L. Maximal androgen blockade for advanced prostate cancer. Best Pract Res Clin Endocrinol Metab 2008, 22:331-340.
38. Diamanti-Kandarakis E, Mitrakou A, Raptis S, Tolis G, Duleba AJ. The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome. J Clin Endocrinol Metab 1998, 83:2699-2705.
39. Müderris II, Bayram F, Güven M. Treatment of hirsutism with lowest-dose flutamide (62.5 mg/Day). Gynecol Endocrinol 2000, 14:38-41.
40. Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM. Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study. J Periodontol 1999, 70:63-67.
41. Ishida H, Kondoh T, Kataoka M. Factors influencing nifedipine-induced gingival overgrowth in rats. J Periodontol 1995, 66:345-350.
42. Sooriyamoorthy M, Gower DB. Hormonal influences on gingival tissue: relationship to periodontal disease. J Clin Periodontol 1989, 16:201-208.